Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma.

Alexandra M. Levine, MD, Anil Tulpule, MD, Lynne Smith, PhD, Byron M. Espina, AB, Ann F. Mohrbacher, MD, Donald I. Feinstein, MD

Blood (2005) 106 (11): 945.

https://doi.org/10.1182/blood.V106.11.945.945

Published: 2005

Journal Articles

A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL).

Ann Mohrbacher, M.D., Shamel Sanani, M.D., David Irwin, M.D., Byron M. Espina, Catherine Madrid, Luigi Lenaz, M.D., Rosamerlinda Rosales

Blood (2004) 104 (11): 4592.

https://doi.org/10.1182/blood.V104.11.4592.4592

Published: 2004

Journal Articles

Treatment of Anemia with Aranesp® (Darbepoetin-alfa) Given Once Every Two Weeks in HIV Seropositive Patients.

Anil Tulpule, M.D., Dharshika Dharmapala, Pamela Burian, PA-C, Byron M. Espina, Gerald Jayne, Shelly George, M.D., Alexandra M. Levine, M.D.

Blood (2004) 104 (11): 3108.

https://doi.org/10.1182/blood.V104.11.3108.3108

Published: 2004

Journal Articles

Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome–related lymphoma

Lasika Seneviratne, Byron M. Espina, Bharat N. Nathwani, Joel A. Chan, Russell K. Brynes, Alexandra M. Levine

Blood (2001) 98 (8): 2358–2363.

https://doi.org/10.1182/blood.V98.8.2358

Published: 2001

Journal Articles

Evolving characteristics of AIDS-related lymphoma

Alexandra M. Levine, Lasika Seneviratne, Byron M. Espina, Amy Rock Wohl, Anil Tulpule, Bharat N. Nathwani, Parkash S. Gill

Blood (2000) 96 (13): 4084–4090.

https://doi.org/10.1182/blood.V96.13.4084

Published: 2000

NARROW

Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma.

A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL).

Treatment of Anemia with Aranesp® (Darbepoetin-alfa) Given Once Every Two Weeks in HIV Seropositive Patients.

Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome–related lymphoma

Evolving characteristics of AIDS-related lymphoma

Email alerts

ASH Publications

American Society of Hematology

Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma.

A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL).

Treatment of Anemia with Aranesp® (Darbepoetin-alfa) Given Once Every Two Weeks in HIV Seropositive Patients.

Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome–related lymphoma

Evolving characteristics of AIDS-related lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only